AI and genomics are reshaping early disease detection
Combining biological data with machine learning could improve diagnosis and treatment selection, but clinical validation remains the threshold.
The story
AI for Good has reviewed how machine learning and genomic information are being combined to identify disease signals and support more precise medical decisions.
Genomic datasets are complex and can reveal sensitive information about patients and families. Useful systems need representative data, secure governance and evidence that predictions improve decisions across diverse populations.
The next phase should emphasize prospective clinical studies, explainable results for care teams and equitable access to the diagnostics and therapies that emerge.
INNOVOX analysis
Genomic datasets are complex and can reveal sensitive information about patients and families. Useful systems need representative data, secure governance and evidence that predictions improve decisions across diverse populations.
What to watch
The next phase should emphasize prospective clinical studies, explainable results for care teams and equitable access to the diagnostics and therapies that emerge.
